Annual Current Liabilities
$20.41 M
-$18.38 M-47.39%
December 31, 2023
Summary
- As of February 7, 2025, SMMT annual total current liabilities is $20.41 million, with the most recent change of -$18.38 million (-47.39%) on December 31, 2023.
- During the last 3 years, SMMT annual current liabilities has risen by +$515.00 thousand (+2.59%).
- SMMT annual current liabilities is now -47.39% below its all-time high of $38.78 million, reached on December 31, 2022.
Performance
SMMT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$59.01 M
-$81.16 M-57.90%
September 30, 2024
Summary
- As of February 7, 2025, SMMT quarterly total current liabilities is $59.01 million, with the most recent change of -$81.16 million (-57.90%) on September 30, 2024.
- Over the past year, SMMT quarterly current liabilities has dropped by -$81.16 million (-57.90%).
- SMMT quarterly current liabilities is now -57.90% below its all-time high of $140.17 million, reached on June 30, 2024.
Performance
SMMT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SMMT Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.4% | -57.9% |
3 y3 years | +2.6% | +52.2% |
5 y5 years | +18.8% | +469.4% |
SMMT Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -47.4% | at low | -57.9% | +394.6% |
5 y | 5-year | -47.4% | +48.2% | -57.9% | +469.4% |
alltime | all time | -47.4% | +5726.7% | -57.9% | >+9999.0% |
Summit Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $59.01 M(-57.9%) |
Jun 2024 | - | $140.17 M(+498.0%) |
Mar 2024 | - | $23.44 M(+14.9%) |
Dec 2023 | $20.41 M(-47.4%) | $20.41 M(-82.1%) |
Sep 2023 | - | $113.74 M(+853.3%) |
Jun 2023 | - | $11.93 M(-31.6%) |
Mar 2023 | - | $17.44 M(-55.0%) |
Dec 2022 | $38.78 M(+51.4%) | $38.78 M(+132.5%) |
Sep 2022 | - | $16.68 M(+9.9%) |
Jun 2022 | - | $15.17 M(-33.2%) |
Mar 2022 | - | $22.72 M(-11.3%) |
Dec 2021 | $25.62 M(+28.8%) | $25.62 M(+12.4%) |
Sep 2021 | - | $22.79 M(+4.1%) |
Jun 2021 | - | $21.89 M(-70.0%) |
Mar 2021 | - | $73.05 M(+267.3%) |
Dec 2020 | $19.89 M(+44.5%) | - |
Dec 2020 | - | $19.89 M(+34.9%) |
Sep 2020 | - | $14.74 M(-3.1%) |
Mar 2020 | - | $15.22 M(+46.8%) |
Dec 2019 | $13.77 M(-19.8%) | - |
Oct 2019 | - | $10.36 M(-15.5%) |
Jul 2019 | - | $12.26 M(-7.0%) |
Apr 2019 | - | $13.18 M(-23.3%) |
Jan 2019 | $17.17 M(-47.2%) | - |
Jan 2019 | - | $17.17 M(+9.5%) |
Oct 2018 | - | $15.69 M(+31.4%) |
Jul 2018 | - | $11.94 M(-65.4%) |
Apr 2018 | - | $34.54 M(+6.2%) |
Jan 2018 | $32.53 M(+138.9%) | - |
Jan 2018 | - | $32.53 M(+127.4%) |
Oct 2017 | - | $14.31 M(+4.4%) |
Jul 2017 | - | $13.70 M(+4.0%) |
Apr 2017 | - | $13.17 M(-3.3%) |
Jan 2017 | $13.62 M(+198.3%) | - |
Jan 2017 | - | $13.62 M(+10.8%) |
Oct 2016 | - | $12.30 M(+181.0%) |
Jul 2016 | - | $4.38 M(-4.3%) |
Apr 2016 | - | $4.57 M |
Date | Annual | Quarterly |
---|---|---|
Jan 2016 | $4.57 M(-15.1%) | - |
Jan 2016 | - | $4.57 M(+3.3%) |
Oct 2015 | - | $4.42 M(+4.1%) |
Jul 2015 | - | $4.25 M(-0.2%) |
Apr 2015 | - | $4.25 M(-20.9%) |
Jan 2015 | $5.38 M(+74.5%) | - |
Jan 2015 | - | $5.38 M(+12.3%) |
Oct 2014 | - | $4.79 M(-16.7%) |
Jul 2014 | - | $5.75 M(+86.4%) |
Jan 2014 | $3.08 M(+27.9%) | - |
Jan 2014 | - | $3.08 M(+38.6%) |
Jul 2013 | - | $2.22 M(-7.7%) |
Jan 2013 | $2.41 M(+19.5%) | - |
Jan 2013 | - | $2.41 M(+124.0%) |
Jul 2012 | - | $1.08 M(-46.7%) |
Jan 2012 | $2.02 M(+5.6%) | - |
Jan 2012 | - | $2.02 M(-34.5%) |
Jul 2011 | - | $3.08 M(+61.0%) |
Jan 2011 | $1.91 M(+8.4%) | - |
Jan 2011 | - | $1.91 M(+47.4%) |
Jul 2010 | - | $1.30 M(-26.5%) |
Jan 2010 | $1.76 M(-34.5%) | - |
Jan 2010 | - | $1.76 M(+2.0%) |
Jul 2009 | - | $1.73 M(-35.7%) |
Jan 2009 | $2.69 M(-60.4%) | - |
Jan 2009 | - | $2.69 M(-55.9%) |
Jul 2008 | - | $6.10 M(-10.2%) |
Jan 2008 | $6.79 M(+139.0%) | - |
Jan 2008 | - | $6.79 M(+68.8%) |
Jul 2007 | - | $4.02 M(+41.6%) |
Jan 2007 | $2.84 M(+125.7%) | - |
Jan 2007 | - | $2.84 M(+351.1%) |
Jul 2006 | - | $629.60 K(-50.0%) |
Jan 2006 | $1.26 M(+259.4%) | - |
Jan 2006 | - | $1.26 M(+29.0%) |
Jul 2005 | - | $975.40 K(+178.5%) |
Jan 2005 | $350.20 K | - |
Jan 2005 | - | $350.20 K(+64.3%) |
Jul 2004 | - | $213.20 K |
FAQ
- What is Summit Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Summit Therapeutics?
- What is Summit Therapeutics annual current liabilities year-on-year change?
- What is Summit Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Summit Therapeutics?
- What is Summit Therapeutics quarterly current liabilities year-on-year change?
What is Summit Therapeutics annual total current liabilities?
The current annual current liabilities of SMMT is $20.41 M
What is the all time high annual current liabilities for Summit Therapeutics?
Summit Therapeutics all-time high annual total current liabilities is $38.78 M
What is Summit Therapeutics annual current liabilities year-on-year change?
Over the past year, SMMT annual total current liabilities has changed by -$18.38 M (-47.39%)
What is Summit Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SMMT is $59.01 M
What is the all time high quarterly current liabilities for Summit Therapeutics?
Summit Therapeutics all-time high quarterly total current liabilities is $140.17 M
What is Summit Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SMMT quarterly total current liabilities has changed by -$81.16 M (-57.90%)